Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (641-650 of 685) with videos related to

Pageof 69
Sort By:
Nature Genetics|December 30, 2015
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
International Journal of Epidemiology|July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studySuzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Nature Genetics|September 21, 2010
Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
British Journal of Cancer|March 21, 2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation studySuzanne C Dixon-Suen, Christina M Nagle, Aaron P Thrift, et al.
International Journal of Molecular Sciences|August 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous HistologyLinda E Kelemen, Madalene Earp, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square|November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaDale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Gynecologic Oncology|December 22, 2014
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyAlice W Lee, Jonathan P Tyrer, Jennifer A Doherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 69

Showing results (641-650 of 685) with videos related to

Sort By:
Pageof 69
Nature Genetics|December 30, 2015
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
International Journal of Epidemiology|July 13, 2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization studySuzanne C Dixon, Christina M Nagle, Aaron P Thrift, et al.
The Journal of Pathology. Clinical Research|March 22, 2023
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Eun-Young Kang, Ashley Weir, et al.
Nature Genetics|September 21, 2010
Common variants at 19p13 are associated with susceptibility to ovarian cancerKelly L Bolton, Jonathan Tyrer, Honglin Song, et al.
British Journal of Cancer|March 21, 2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation studySuzanne C Dixon-Suen, Christina M Nagle, Aaron P Thrift, et al.
International Journal of Molecular Sciences|August 24, 2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous HistologyLinda E Kelemen, Madalene Earp, Brooke L Fridley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)Aline Talhouk, Joshy George, Chen Wang, et al.
Research Square|November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaDale Garsed, Tibor Zwimpfer, Sian Fereday, et al.
Gynecologic Oncology|December 22, 2014
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyAlice W Lee, Jonathan P Tyrer, Jennifer A Doherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 31, 2020
Prognostic gene expression signature for high-grade serous ovarian cancerJ Millstein, T Budden, E L Goode, et al.
Pageof 69